Covered recipient · General Payments record
BORIS CEHAJIC
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2018–2024
$20,523.25
- Reported across 115 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $457.33 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $128.71 | 5 |
| Ethicon US, LLC | $75.00 | 2 |
| DAVOL INC. | $59.64 | 2 |
| Kerecis Limited | $58.10 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $41.16 | 2 |
| Merck Sharp & Dohme Corporation | $29.27 | 1 |
| EAGLE PHARMACEUTICALS, INC. | $25.20 | 1 |
| Hologic Sales and Service, LLC | $21.66 | 1 |
| Smith & Nephew, Inc. | $18.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.36 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103431320 | CMS |
| ABBVIE INC. | $24.37 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103431322 | CMS |
| ABBVIE INC. | $23.39 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103431324 | CMS |
| ABBVIE INC. | $26.58 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103431326 | CMS |
| ABBVIE INC. | $30.01 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103431328 | CMS |
| Davol Inc. | $25.64 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127664715 | CMS |
| Davol Inc. | $34.00 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127664717 | CMS |
| EAGLE PHARMACEUTICALS, INC. | $25.20 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120209555 | CMS |
| Ethicon US, LLC | $35.40 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077637044 | CMS |
| Ethicon US, LLC | $39.60 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077637002 | CMS |
| Hologic Sales and Service, LLC | $21.66 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084895453 | CMS |
| Kerecis Limited | $58.10 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120091931 | CMS |
| Merck Sharp & Dohme LLC | $29.27 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141695664 | CMS |
| Smith+Nephew, Inc. | $18.59 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149591321 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.77 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137505521 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.39 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137505525 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.